Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIntegrated Home Care Auvelity Step Therapy | OpenP…
    Ask Trek AI about this page
    CurrentIntegrated Home Care ServicesPolicy 26408

    Auvelity Step Therapy Coverage

    Customize your policy alerts

    Sign up for integrated_home_care_services Policy 26408 alerts

    Get alerted when Policy 26408 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs step-therapy authorization for Auvelity requests under the Integrated Home Care Services formulary. Automatic approval is available when the member has tried or cannot use specified generic antidepressant therapies, with an exception for agitation associated with dementia due to Alzheimer’s disease.

    Policy Summary
    PayerIntegrated Home Care Services
    PolicyAuvelity Step Therapy Coverage
    Policy CodePolicy 26408
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionConfirm that the member has tried or cannot use at least one qualifying generic antidepressant therapy before requesting Auvelity approval.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1Step-therapy criterion
    4Generic alternative categories
    4Example generic SSRIs
    2Example generic SNRIs
    1

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Clinical exception

    Auvelity Coverage Criteria

    Initial Auvelity Therapy

    Automatic approval is granted when any one of the following qualifying therapies has been tried or cannot be used.

    Qualifying generic antidepressant therapy

    • Generic SSRI: A generic SSRI, including citalopram, fluoxetine, paroxetine, or sertraline.
    • Generic SNRI: A generic SNRI, including venlafaxine or duloxetine.
    • Generic bupropion: A generic bupropion product.75mg/100mg IR; 100mg/150mg/200mg SR; or 150mg/300mg XL
    • Mirtazapine.

    Provider Requirements

    Step Therapy

    Automatic Approval for Auvelity

    Requests for Auvelity will receive automatic approval when the member has tried or cannot use a qualifying generic antidepressant alternative. This requirement does not apply to members with agitation associated with dementia due to Alzheimer’s disease.

    Documentation Required

    Qualifying Generic Antidepressant Therapy

    Document that the member has tried or cannot use at least one qualifying generic antidepressant therapy category or product listed below.

    • Generic SSRI, such as citalopram, fluoxetine, paroxetine, or sertraline
    • Generic SNRI, such as venlafaxine or duloxetine
    • Generic bupropion product: 75 mg or 100 mg immediate-release (IR); 100 mg, 150 mg, or 200 mg sustained-release (SR); or 150 mg or 300 mg extended-release (XL)
    • Mirtazapine

    Policy Background

    Auvelity requests are subject to step therapy with commonly available generic antidepressant alternatives, including a generic SSRI, generic SNRI, generic bupropion product, or mirtazapine. The step-therapy requirement is not required for members with agitation associated with dementia due to Alzheimer’s disease.

    Initial Auvelity Authorization

    Auvelity Initial Authorization

    Automatic approval is given when the member has tried or cannot use a qualifying generic antidepressant therapy.

    Qualifying antidepressant alternative: The member has tried or cannot use a generic SSRI, generic SNRI, generic bupropion product, or mirtazapine.

    This criterion is not required for members with agitation associated with dementia due to Alzheimer's disease.

    Required Generic Antidepressant Step

    StepRequirementQualifying alternativesException
    1The member must have tried or be unable to use at least one qualifying generic antidepressant before Auvelity approval.Generic SSRI: citalopram, fluoxetine, paroxetine, or sertraline; generic SNRI: venlafaxine or duloxetine; generic bupropion product; or mirtazapine.This criterion is not required for members with agitation associated with dementia due to Alzheimer’s disease.
    Policy Summary
    PayerIntegrated Home Care Services
    PolicyAuvelity Step Therapy Coverage
    Policy CodePolicy 26408
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionConfirm that the member has tried or cannot use at least one qualifying generic antidepressant therapy before requesting Auvelity approval.
    SourceLink
    On This Page
    Auvelity Coverage CriteriaProvider RequirementsPolicy BackgroundInitial Auvelity AuthorizationRequired Generic Antidepressant Step